Sage Journals: Discover world-class research

Abstract

An unlicensed medicine is a medication that has not been approved for use by the Medicines and Healthcare products Regulatory Agency. In England, unlicensed medicines account for just under 1% of all community prescriptions, and thus, prescribers will encounter them relatively regularly during their working life. It is important to know the evidence-based guidelines about unlicensed medicines before prescribing them.

Get full access to this article

View all access options for this article.

References

Avery

Anderson

Bond

, et al. (2011) Evaluation of patient reporting of adverse drug reactions to the UK ‘Yellow Card Scheme': Literature review, descriptive and qualitative analyses, and questionnaire surveys. Health Technology Assessment 15(20): 1–234. DOI: 10.3310/hta15200.

Bellis

Kirkham

Nunn

, et al. (2014) Adverse drug reactions and off-label and unlicensed medicines in children: A prospective cohort study of unplanned admissions to a paediatric hospital. British Journal of Clinical Pharmacology 77(3): 545–553. DOI: 10.1111/bcp.12222.

Bourns

(2017) Unlicensed medicines in the UK – legal frameworks, risks, and their management. Medicine Access @ Point of Care 1(1): 22–28. DOI: 10.5301/maapoc.0000006.

British National Formulary (2021) Melatonin. Available at: https://bnf.nice.org.uk/drug/melatonin.html (accessed 23 December 2021).

Chisholm

(2012) Exploring UK attitudes towards unlicensed medicines use: A questionnaire-based study of members of the general public and physicians. International Journal of General Medicine 5: 27–40. DOI: 10.2147/IJGM.S28341.

Donovan

Parkin

Brierley-Jones

, et al. (2018) Unlicensed medicines use: A UK guideline analysis using AGREE II. International Journal of Pharmacy Practice 26(6): 515–525. DOI: 10.1111/ijpp.12436.

GMC (2021) Good practice in prescribing and managing medicines and devices. Available at: www.gmc-uk.org/-/media/documents/prescribing-guidance-updated-english-20210405_pdf-85260533.pdf?la=en&hash=716B06E30FA2D9CA7700B94B3F55173B10F3058A (accessed 14 October 2021).

Hull University Teaching Hospitals (2020) “Unlicensed” and “Off-Label” medicines. Available at: www.hey.nhs.uk/patient-leaflet/unlicensed-off-label-medicines/ (accessed 20 October 2021).

Lenk

Koch

Zappel

, et al. (2009) Off-label, off-limits? Parental awareness and attitudes towards off-label use in paediatrics. European Journal of Paediatrics 168(12): 1473–1478. DOI: 10.1007/s00431-009-0956-6.

10.

Medical Defence Union (2014) Co-prescribing unlicensed medicines with a GP. Available at: www.themdu.com/guidance-and-advice/guides/ethical-dilemmas/co-prescribing-unlicensed-medicines-with-a-gp (accessed 20 October 2021).

11.

Medicines for Children (2020) Unlicensed medicines. Available at: www.medicinesforchildren.org.uk/advice-guides/general-advice-for-medicines/unlicensed-medicines/ (accessed 25 November 2021).

12.

MHRA (2014a) The supply of unlicensed medicinal products (“specials”). Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/373505/The_supply_of_unlicensed_medicinal_products__specials_.pdf (accessed 14 October 2021).

13.

MHRA (2014b) Off-label or unlicensed use of medicines: Prescribers’ responsibilities. Available at: www.gov.uk/drug-safety-update/off-label-or-unlicensed-use-of-medicines-prescribers-responsibilities#a-licensed-medicine-meets-acceptable-standards-of-efficacy-safety-and-quality (accessed 20 October 2021).

14.

MHRA (2021) Yellow card. Available at: https://yellowcard.mhra.gov.uk/the-yellow-card-scheme/ (accessed 20 October 2021).

15.

NHS Greater Glasgow and Clyde (2019) Section 9: Unlicensed medicines policy section. Available at: https://ggcmedicines.org.uk/media/uploads/policies/section_9/9.1_unlicensed_medicines_policy_-_final_1910.pdf (accessed 14 October 2021).

16.

Pavis

Wilcock

(2001) Prescribing of drugs for use outside their licence in palliative care: Survey of specialists in the United Kingdom. British Medical Journal 323: 484–485. DOI: 10.1136/bmj.323.7311.484.

17.

RCGP. Professional topic guide: Improving quality safety and prescribing: Available at: www.rcgp.org.uk/training-exams/training/gp-curriculum-overview/professional-topic-guides.aspx#quality (accessed 10 February 2022).

18.

Royal College of Paediatrics and Child Health (2013) The use of unlicensed medicines or licensed medicines for unlicensed applications in paediatric practice. Available at: www.rcpch.ac.uk/resources/use-unlicensed-medicines-or-licensed-medicines-unlicensed-applications-paediatric#consent-of-parents-carers-and-patients (accessed October 2021).

19.

Sutherland

Waldek

(2015) It is time to review how unlicensed medicines are used. European Journal of Clinical Pharmacology 71(9): 1029–1035. DOI: 10.1007/s00228-015-1886-z.

20.

Turner

Nunn

Fielding

, et al. (1999) Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: A prospective study. Acta Paediatrica, International Journal of Paediatrics 88(9): 965–968. DOI: 10.1080/08035259950168469.

Unlicensed medicine prescribing in general practice

Abstract

Get full access to this article

References